===== DISCHARGE NOTE =====
note_id=14095761-DS-9 | hadm_id=24391636

 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Latex / Nsaids
 
Attending: ___
 
Chief Complaint:
Hyperglycemia, Abdominal Pain

 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
This is a ___ year old lady wi with PMH of Type I DM and 
malignant melanoma who presented to the ED with hyperglycemia 
and abdominal pain.

She reports that when she awoke this morning she was not feeling 
her usual self and found her blood sugar to be in the mid ___. 
She took her insulin per her regular pump indications for 
sliding scale but on serial rechecks her BS were persistently in 
the 300s.  Over the course of the day she slowly developed 
epigastric abdominal pain associated w/ nausea and ultimately 
emesis.  She denied fevers, chills, cough, or diarrhea. 

In the ED, initial VS were:  98.0 ___ 18 98%.   Initial 
labs were significant for WBC 22.4, Hct 46, Cr 1.1, K+ 5.2, Hc03 
11, glucose of 547 and lactate of 4.4. In the setting of 
abdominal pain on exam and leukocytosis, a CT abdomen and pelvis 
was performed with contrast which ruled out on preliminary read 
an acute process. For her anion gap acidosis she was started on 
an insulin gtt for treatment of DKA and given IVF 4L NS and 
started on vancomycin and zosyn for her elevated lactate. A 
repeat lactate decreased to 3.0. An VBG 7.___. A chest xray 
was clear. Blood cultures were drawn. Vitals on transfer were.
  
On arrival to the MICU,  pt was stable with VS: 98.6 113 108/49 
100% RA 18.
 
Past Medical History:
1) T1DM: Seen at ___ in ___ by Dr. ___. 
Diagnosed ___ at age ___. Has insulin pump and checks BS tid. 
Had dilated eye exam ___. +h/o progressive retinopathy. Last 
seen by podiatry ___. Last known A1c: 9.1 in ___ Focal nodular hyperplasia, followed with serial U/S by GI 
clinic  
3) h/o malignant melanoma, ___ level IV, dx ___, left upper 
arm, s/p wide excision and negative sentinel node biopsy, no 
further tx. Had second primary ___ level IV in ___, s/p wide 
excision with no sentinel node procedure.  
4) Anticardiolipin Ab  
5) HTN  
6) h/o vitreal hemmorhage  
7) h/o chronic sinusitis, seen by ENT over last year  
8) migraine headaches  
9) LBP with disc herniation L5-S1, with compression of L S1 root 

10) Infertility, s/p intrauterine fertilization  
11) Fibroid uterus  
 
Social History:
___
Family History:
NC
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
Vitals: T: 98.6 BP:108/49 P:113 R:18 O2: 100% on RA 
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  
Neck: supple, JVP not elevated, no LAD  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no organomegaly  
GU: no foley  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNII-XII intact, ___ strength upper/lower extremities, 
grossly normal sensation, 2+ reflexes bilaterally, gait 
deferred, finger-to-nose intact  
.
DISCHARGE PHYSICAL EXAM:
Vitals: T: 98.6 BP:112/51 P:101 R:18 O2: 100% on RA 
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  
Neck: supple, JVP not elevated, no LAD  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no organomegaly  
GU: no foley  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNII-XII intact, ___ strength upper/lower extremities, 
grossly normal sensation, 2+ reflexes bilaterally, gait 
deferred, finger-to-nose intact  

 
Pertinent Results:
Admission:
___ 12:03AM   GLUCOSE-547* UREA N-22* CREAT-1.1 SODIUM-134 
POTASSIUM-5.2* CHLORIDE-92* TOTAL CO2-11* ANION GAP-36*
___ 12:03AM   WBC-22.4*# RBC-4.95 HGB-15.0 HCT-46.8 MCV-95 
MCH-30.3 MCHC-32.0 RDW-12.8
___ 12:03AM   NEUTS-85.9* LYMPHS-12.1* MONOS-1.3* EOS-0.2 
BASOS-0.5
___ 12:20AM   LACTATE-4.4*
___ 01:45AM   LACTATE-3.0*
___ 03:17AM   ___ PO2-49* PCO2-32* PH-7.19* TOTAL 
CO2-13* BASE XS--14 COMMENTS-GREEN TOP

Discharge:

___ 07:01AM BLOOD WBC-15.5* RBC-4.07* Hgb-12.3 Hct-36.6# 
MCV-90 MCH-30.1 MCHC-33.5 RDW-12.5 Plt ___
___ 07:01AM BLOOD Neuts-72.5* ___ Monos-3.9 Eos-0.3 
Baso-0.5
___ 03:01AM BLOOD Glucose-99 UreaN-14 Creat-0.6 Na-139 
K-4.1 Cl-111* HCO3-20* AnGap-12
___ 03:01AM BLOOD Calcium-8.3* Phos-3.1 Mg-1.8
 
Brief Hospital Course:
This is a ___ yo lady with PMH of Type I DM and malignant 
melanoma who presents with an anion gap acidemia in the setting 
of elevated lactate and glucose in addition to a leukocytosis of 
unclear source. 

# Metabolic Acidemia: Pt had AG metabolic acidosis upon arrival 
to MICU, most likely ___ to DKA considering history of 
uncontrolled blood glucose. AG metabolic acidosis could also be 
___ lactic acidosis given her elevated lactate of 4.4 (now 
downtrending to 3.0).  Her elevated lactate may be associated 
with pt's DKA or associated with potential toxic ingestion of 
salicylates (pt currently taking Aspirin).  Given that bicarb 
may worsen the hypokalemia and hyperosmolarity observed in DKA, 
bicarbonate was avoided in empiric treatment of lactic acidosis. 
 Patient's lactate stabilized during hospitalization. Repeat ABG 
showed resolution of acidemia.  Patient received aggressive 
fluid resuscitation with D5 NS + K.  Patient was restarted on 
insulin drip and converted to insulin sliding scale per 
recommendation from ___ Endocrinology.

# Hyperglycemia/Insulin Dependant Diabetes:  Pt had a blood 
glucose of 547 upon transfer to the MICU as well as an AG of 36. 
___ Endocrinology found that the patient's insulin pump was 
malfunctioning and the likely cause of this episode of DKA.

#Leukocytosis: The patient was admitted with an elevated WBC of 
22.4.  The patient had no clear source of infection (clinically 
afebrile with negative blood cultures and negative abdominal CT 
and CXR).  Leukocytosis was most likely in association with DKA. 
During the patient's hospitalization, her WBC downtrended.

#HYPERLIPIDEMIA: Patient was continued on home dose of 
simvastatin.

#HTN: Patient was continued on home moexipril.
.
===================
TRANSITION OF CARE:
- Pt had leukocytosis during hospitalization, no suspected 
infectious focus: please recheck CBC at PCP appointment, and 
follow up blood cultures
- Pt needs more diabetes education (possibly reusing lancets for 
fingersticks) 
 
Medications on Admission:
INSULIN PUMP (HUMALOG INSULIN) 
MOEXIPRIL [UNIVASC] - 15 mg Tablet - 1 Tablet(s) by mouth once a 
day
SIMVASTATIN  
ASPIRIN [BABY ASPIRIN] 
MULTIVITAMIN WITH MINERALS 
PYRIDOXINE [VITAMIN B-6]  

 
Discharge Medications:
1. moexipril 15 mg Tablet Sig: One (1) Tablet PO once a day.  
2. Insulin Pump IR1250     Misc Sig: humalog insulin  
Miscellaneous as directed: humalog insulin pump per previous 
home regimen.  
3. Aspir-81 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) 
Tablet, Delayed Release (E.C.) PO once a day.  
4. multivitamin     Tablet Sig: One (1) Tablet PO once a day.  
5. simvastatin  Oral
6. pyridoxine  Oral

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Diabetic ketoacidosis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure participating in your care at ___ 
___. You were admitted to the hospital with 
high blood sugars (diabetic ketoacidosis). You were started on 
an insulin drip to treat your high blood sugars.  You also 
received IV fluids because you were dehydrated and to fix your 
electrolyte imbalance.  Your white blood cell count was also 
higher than normal, but we found no sign of infection and your 
white blood cell count has decreased over the past two days.  
You were seen by ___ who examined your insulin pump and found 
that your pump was malfunctioning, and because you were not 
receiving insulin, your blood sugars were high.

.
Please attend the follow up appointments listed below with your 
primary care doctor and your ___ physician.
.
We did not make any changes to your home medications. Please 
continue taking them as you were prior to hospitalization. Per 
your endocrinologist, your Pump ___ insulin plan is:

Home pump settings (units/hr):
Midnight 1
5am      1.8
7am      1.4
10a      0.8
12p      0.6
6p       0.6
Insulin drip @ 1.5 units/hr.

___-- 1:11g breakfast, 1:10g lunch, 1:8g dinner
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14095761-DS-8 | hadm_id=25428685

 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Latex
 
Attending: ___.
 
Chief Complaint:
DKA
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ yo W with PMH of Type I DM and malignant melanoma who 
developed nausea, vomitiing, fatigue day of admission. Pt had 
been away in ___ with her family over the weekend. She 
was feeling well on ___, but did not sleep well ___ 
night. ___ morning, she awoke feeling weak and with diffuse 
achiness. She stayed in bed during the day while her husband and 
family were out. She continued to feel worse at the time they 
returned, and family decided to drive back home. En route, she 
developed nausea and vomiting (4 times over 4 hours). She 
recently had last dose of adjuvant chemotherapy on ___ and 
was doing well. 
.
In the ED, VS: T 95.7, HR 98, BP 117/57, RR 24, 99%RA. Patient 
received 3L NS, 8U of Insulin IV and was started on Insulin gtt. 
Labs were notable for AG of 37, VBG of ___.
.
ROS: + productive cough; denies subjective fevers/chills, 
abdominal pain, chest pain, joint pain, rashes, sick contacts
.

 
Past Medical History:
) T1DM: Seen at ___ in ___ by Dr. ___. 
Diagnosed ___ at age ___. Has insulin pump and checks BS tid. 
Had dilated eye exam ___. +h/o progressive retinopathy. Last 
seen by podiatry ___. Last known A1c: 9.1 in ___ Focal nodular hyperplasia, followed with serial U/S by GI 
clinic  
3) h/o malignant melanoma, ___ level IV, dx ___, left upper 
 
arm, s/p wide excision and negative sentinel node biopsy, no 
further tx. Had second primary ___ level IV in ___, s/p wide 
excision with no sentinel node procedure.  
4) Anticardiolipin Ab  
5) HTN  
6) h/o vitreal hemmorhage  
7) h/o chronic sinusitis, seen by ENT over last year  
8) migraine headaches  
9) LBP with disc herniation L5-S1, with compression of L S1 root 
 
10) Infertility, s/p intrauterine fertilization  
11) Fibroid uterus  

 
Social History:
___
Family History:
NC
 
Physical Exam:
Tmax: 37.6 째C (99.7 째F)
Tcurrent: 36.6 째C (97.8 째F)
HR: 85 (85 - 109) bpm
BP: 134/52(73) {82/40(55) - 140/73(88)} mmHg
RR: 20 (13 - 23) insp/min
SpO2: 94% 

GEN: NAD, fatigued
HEENT: EOMI, PERRL
NECK: Supple 
CHEST: CTABL, no w/r/r
CV: RRR, S1S2, no m/r/g
ABD: Soft/NT/ND, + BS
EXT: no cyanosis or edema
SKIN: warm , no rashes
NEURO: AAO x 3, CN, strength, sensation grossly intact

 
Brief Hospital Course:
___ yo W with PMH of Type I DM and malignant melanoma 
presents with DKA likely secondary to viral illness.
.
DKA: Pt is a type I diabetic on insulin pump and followed by 
___.  Pt presented with lack of sleep, fatigue, cough, sore 
throat, for several days.  Possible DKA precipitated by 
infection (viral illness URI) and/or insulin pump dysfunction.  
Pt presented with glucose >1000 and ph 6.99, bicarb 7.  Given 
fluids and started on an insulin gtt and sent to the ICU.  Pt 
was given aggressive hydration. The patient's gap closed 
overnight and switched to started lantus 22units sc qhs and 
sliding scale (while on pump total basal dose per day is 
25units). 
On the medical floor, the patient underwent insulin pump testing 
that, after subsequent relocation of the injection site away 
from potentially scarred abdominal tissue, worked appropriately. 
 The ___ service consulted on the patient when on the medical 
floor.
The patient was discharged home to f/u closely with ___.

ARF: Likely ___ to DKA and dehydration. Resolved after IVF 
administration.

DM 1 uncontrolled with complications: 
See above.

Melanoma: Hem/Onc was notified.  Continue interferon treatment 
as outpatient.

 
Medications on Admission:
ASA 81 mg 
Compazine 10mg PO q6hrs nausea
Fioricet
Insulin Pump
MVI
Naproxyn
Rhinocort
univasc 15mg PO daily 
Vitamin B 6

 
Discharge Medications:
1. Sucralfate 100 mg/mL Suspension Sig: Ten (10) mL PO four 
times a day as needed for heartburn: Take for 14 days and then 
only as needed thereafter.
Disp:*1 bottle* Refills:*6*
2. Multivitamin     Tablet Sig: One (1) Tablet PO once a day.  
3. Vitamin B-6 200 mg Tablet Sustained Release Sig: One (1) 
Tablet Sustained Release PO once a day: TAKE PRIOR OUTPATIENT 
DOSE.  
4. Moexipril 15 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

5. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO twice a day.
Disp:*60 Capsule, Delayed Release(E.C.)(s)* Refills:*4*
6. Rhinocort Aqua 32 mcg/Actuation Spray, Non-Aerosol Sig: One 
(1) spray Nasal once a day: TAKE PER PRIOR OUTPATIENT DOSAGE AND 
FREQUENCY.  
7. Compazine 10 mg Tablet Sig: One (1) Tablet PO every six (6) 
hours as needed for nausea.
Disp:*30 Tablet(s)* Refills:*0*
8. Zofran 4 mg Tablet Sig: One (1) Tablet PO every eight (8) 
hours as needed for nausea.
Disp:*30 Tablet(s)* Refills:*0*
9. Interferon Alfa-2B 6,000,000 unit/mL Solution Sig: One (1) 
dose Injection once a month: NOTE: TAKE INTEFERON TYPE, DOSING 
NAD FREQUENCY PER ONCOLGISTS.  THE ABOVE IS NOT CORRECT 
INTERFERON DOSE, FREQUENCY AND TYPE.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Diabetic Ketoacidosis
Upper GI Bleed
 
Discharge Condition:
Vital Signs Stable
 
Discharge Instructions:
Return to ED if having high ___ not able to be adequetely 
controlled with insulin pump, red blood or brown coffee-grind 
appearance in vomit, copious black tarry stool, 
light-headedness.

DO NOT USE NAPROXYN, MOTRIN OR ASPIRIN UNTIL DISCUSSION WITH 
PCP.
 
Followup Instructions:
___
